0.82
-0.1259(-13.36%)
Currency In USD
| Previous Close | 0.94 |
| Open | 0.9 |
| Day High | 0.91 |
| Day Low | 0.78 |
| 52-Week High | 4.6 |
| 52-Week Low | 0.52 |
| Volume | 1.27M |
| Average Volume | 876,323 |
| Market Cap | 69.48M |
| PE | -0.31 |
| EPS | -2.6 |
| Moving Average 50 Days | 0.95 |
| Moving Average 200 Days | 1 |
| Change | -0.13 |
If you invested $1000 in Sutro Biopharma, Inc. (STRO) since IPO date, it would be worth $53.7 as of November 09, 2025 at a share price of $0.816. Whereas If you bought $1000 worth of Sutro Biopharma, Inc. (STRO) shares 5 years ago, it would be worth $47.88 as of November 09, 2025 at a share price of $0.816.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
GlobeNewswire Inc.
Nov 05, 2025 9:05 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it will
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced its participa
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
GlobeNewswire Inc.
Sep 29, 2025 9:05 PM GMT
– Extends cash runway into at least mid-2027 – SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug